Skip to main content
. 2012 Dec 31;39(4):182–186. doi: 10.5653/cerm.2012.39.4.182

Figure 5.

Figure 5

Transvaginal ultrasonogram of the patient who underwent sclerotherapy to the left hydrosalpinx 2 weeks earlier (same patient as Figure 1). LO, left ovary.